TELA Bio (TELA) Deferred Taxes (2025)

TELA Bio's (TELA) quarterly Deferred Taxes came in at $7.2 million in Q4 2025, up 21809.09% quarter-over-quarter from $33000.0 in Q2 2025.

TELA Bio (TELA) Deferred Taxes (2025) Analysis & Trends

TELA Bio's Deferred Taxes history runs 1 years deep, the most recent figure standing at $7.2 million for Q4 2025.

On a quarterly basis, Deferred Taxes changed N/A year-over-year to $7.2 million in Q4 2025; TTM through Dec 2025 was $7.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.3 million, up 5179.86% from the prior year.
Deferred Taxes climbed to $7.2 million in Q4 2025 per TELA's latest filing, from $33000.0 in the prior quarter.
Across five years, Deferred Taxes topped out at $7.2 million in Q4 2025 and bottomed at $33000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Abbott Laboratories	180.89 Bn	173.59 Bn	6.27 Bn	-
2	Stryker	127.82 Bn	124.94 Bn	3.81 Bn	-33.00 Mn
3	Medtronic	107.49 Bn	98.27 Bn	6.41 Bn	-8.00 Mn
4	Boston Scientific	67.24 Bn	65.78 Bn	3.61 Bn	-351.00 Mn
5	Edwards Lifesciences	48.02 Bn	44.34 Bn	1.29 Bn	-9.40 Mn
6	Dexcom	28.25 Bn	27.14 Bn	750.30 Mn	7.30 Mn
7	GE HealthCare Technologies	28.17 Bn	25.89 Bn	1.98 Bn	-
8	Smith & Nephew	26.72 Bn	26.14 Bn	-	-
9	Koninklijke Philips	25.31 Bn	22.19 Bn	2.07 Bn	51.51 Mn
10	TELA Bio	38.93 Mn	-606,567.35	12.52 Mn	-

Download Data